Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Tetraspan(in)-mediated immune regulation in hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8⁺ T cell cytotoxic function in hepatocellular carcinoma”

Seo Hee Jin, Dong Joo Kim, Jung Weon Lee

Clin Mol Hepatol. 2025;31(2):650-653. Published online February 11, 2025

DOI: https://doi.org/10.3350/cmh.2025.0109

View: 893 Download: 77

Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”

Valerie Chew

Clin Mol Hepatol. 2025;31(2):642-645. Published online January 16, 2025

DOI: https://doi.org/10.3350/cmh.2025.0031

View: 994 Download: 50 Web of Science: 1 Crossref: 1

Correspondence

Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”

Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su

Clin Mol Hepatol. 2025;31(1):e96-e97. Published online November 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0999

View: 831 Download: 13

Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”

Sang Bae Lee, KyeongJin Kim

Clin Mol Hepatol. 2025;31(1):e78-e80. Published online September 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0750

View: 1116 Download: 73

Reply to Correspondence

Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”

Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):1042-1043. Published online August 27, 2024

DOI: https://doi.org/10.3350/cmh.2024.0685

View: 1496 Download: 32 Web of Science: 1 Crossref: 3

Correspondence

Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong

Clin Mol Hepatol. 2024;30(4):994-996. Published online July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0552

View: 1545 Download: 37 Web of Science: 1 Crossref: 1

Original Article

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression

Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim

Clin Mol Hepatol. 2024;30(4):895-913. Published online August 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0364

View: 3140 Download: 320 Web of Science: 2 Crossref: 2

Editorial

Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

Beom Kyung Kim

Clin Mol Hepatol. 2024;30(4):656-658. Published online July 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0499

View: 1468 Download: 42 Crossref: 2

Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”

Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):653-655. Published online July 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0482

View: 1952 Download: 70 Web of Science: 2

Review

Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu

Clin Mol Hepatol. 2024;30(3):326-344. Published online April 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0155

View: 4180 Download: 171 Web of Science: 10 Crossref: 7

Editorial

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

Carlos Jose Pirola, Silvia Sookoian

Clin Mol Hepatol. 2024;30(2):174-176. Published online February 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0082

View: 3306 Download: 85 Web of Science: 1 Crossref: 2

The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B

Xianhua Mao, Lung Yi Mak, Wai-Kay Seto

Clin Mol Hepatol. 2023;29(3):690-692. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0173

View: 3291 Download: 113 Web of Science: 2 Crossref: 2

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Clin Mol Hepatol. 2023;29(2):390-393. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059

View: 4057 Download: 69 Web of Science: 2 Crossref: 2

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 4241 Download: 73 Web of Science: 1

Review

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 12497 Download: 260 Web of Science: 48 Crossref: 43

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2019;25(2):168-171. Published online February 11, 2019

DOI: https://doi.org/10.3350/cmh.2018.1014

View: 6974 Download: 190 Web of Science: 5 Crossref: 5

4

A Case of Complete Remission in Ruptured Hepatocellular Carcinoma after One - time Transcatheter Arterial Chemoembolization

Doo Yul Ryu,Duc Ky Lee,Jong Hyung Kim,Hyun Min Shin,Dong In Hwang,Dong Joo Lee,Sang Kook Han,Seok En Kim,Suk Joon Park

Clin Mol Hepatol. 1999;5(4):343-347. Published online January 1, 2000

View: 2560 Download: 14

3

Serum Concentration of Intercellular Adhesion Molecule-1 (ICAM-1) in Patients with Hepatocellular Carcinoma (HCC) with Low AFP

Hyun Ju Park, Joung Il Lee, Seok Ho Dong, Hyo Jong Kim, Byoung Ho Kim, Young Woon Chang and Rin Chang

Clin Mol Hepatol. 1998;4(4):346-357. Published online January 1, 2000

View: 2656 Download: 14

Editorial

Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma

Valerie Chew

Received March 25, 2025 Accepted March 28, 2025

DOI: https://doi.org/10.3350/cmh.2025.0334 [Accepted]

View: 499 Download: 41

Original Article

MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation

Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia

Received December 24, 2024 Accepted April 8, 2025

DOI: https://doi.org/10.3350/cmh.2024.1163 [Accepted]

View: 1211 Download: 199

Editorial

Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma

Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received May 9, 2025 Accepted May 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0515 [Accepted]

View: 411 Download: 42

Reply to Correspondence

Reply to correspondence on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”

Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received May 26, 2025 Accepted May 30, 2025

DOI: https://doi.org/10.3350/cmh.2025.0564 [Accepted]

View: 217 Download: 8

Review

Prospects of Mendelian Randomization in Hepatology: A Comprehensive Literature Review with Practice Guidance Mendelian randomization and hepatology

Lanlan Chen, Qi Rao, Menghan Gao, Guoyue Lv, Frank Tacke

Received May 16, 2025 Accepted June 3, 2025

DOI: https://doi.org/10.3350/cmh.2025.0541 [Accepted]

View: 526 Download: 49

1 |

Viewed By 12270	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7643	MAFLD: How is it different from NAFLD?
Viewed By 6663	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5928	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5530	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 338	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search